The FDA website maintains a database of Postmarketing Study Commitments on all approved drugs. Postmarketing Study Commitments are requests that the FDA makes to companies at drug approval times e.g. “your drug is approved though we want you to do a 6 month trial in geriatric patients and report out on your results”.
It’s an interesting resource to find out what the FDA’s thinking is on particular therapies, and to see how they change over time.
A word of caution, like other FDA databases it may not be 100% complete – so if you are making a critical decision based on this data go back and check the approval letters.
FDA Post Marketing Study Commitments
Categories: FDA · Regulatory
Attached are some highlights from an analysis of Biotechnology drugs that I recently carried out. It is an analysis of recombinant therapies only. I’ll probably have some more info to add to this over the next week or so as I delve deeper in to the data I collected.
Recombinant Drug Approvals
Categories: Biotechnology · FDA · Industry data · Regulatory · Statistics · US
Bio-reagent manufacturers have, for a long time, held the tradition of creating beautiful diagrams of cell signalling pathways and biological systems. These are a few sites that I tend to go to when learning about new signalling systems:
Cell Signaling
R&D Systems
EMD Biosciences
E Biosciences
Sigma Aldrich
(Image from Cell Signaling Website)
Categories: Biomedical · Biotechnology · Images · Reference
This is an interesting tool from Search-This.com that shows how internet search engines are interrelated. You can see which search engine feeds off another and who owns who.
Categories: Google · Search Engines · Searching
